Search

Author/Creator Schnitzler, Fabian

3. Early Start of Infliximab in Crohn's Disease Increases Rates of Endoscopic Remission and Decreases Stenosis Formation: Experiences From a Single Center Cohort. Issue 3 (17th August 2021)

Authors:
Schnitzler, Fabian; Seitz, Theresia; Tillack-Schreiber, Cornelia; Lange, Silke; Waggershauser, Constanze; Ochsenkühn, Thomas
Journal:
Crohn's & colitis 360
Issue:
Volume 3:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD Patients. (24th August 2022)

Authors:
Waggershauser, Constanze Heike; Tillack-Schreiber, Cornelia; Weyh, Paul; Alt, Eckard; Siegmund, Thorsten; Berchthold-Benchieb, Christine; Szokodi, Daniel; Schnitzler, Fabian; Ochsenkühn, Thomas
Other Names:
Granito Alessandro Academic Editor.
Journal:
Canadian journal of gastroenterology & hepatology
Issue:
Volume 2022(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. Issue 1 (13th January 2022)

Authors:
Stallhofer, Johannes; Veith, Lisa; Diegelmann, Julia; Probst, Philipp; Brand, Stephan; Schnitzler, Fabian; Olszak, Torsten; Török, Helga; Mayerle, Julia; Stallmach, Andreas; Beigel, Florian
Journal:
Clinical and translational gastroenterology
Issue:
Volume 13:Issue 1(2022)
Page Start:
e00450
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status. Issue 10 (October 2015)

Authors:
Stallhofer, Johannes; Friedrich, Matthias; Konrad-Zerna, Astrid; Wetzke, Martin; Lohse, Peter; Glas, Jürgen; Tillack-Schreiber, Cornelia; Schnitzler, Fabian; Beigel, Florian; Brand, Stephan
Journal:
Inflammatory bowel diseases
Issue:
Volume 21:Issue 10(2015:Oct.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti‐TNF alpha antibodies. (30th April 2014)

Authors:
Beigel, Florian; Steinborn, Anni; Schnitzler, Fabian; Tillack, Cornelia; Breiteneicher, Simone; John, Jestinah Mahachie; Van Steen, Kristel; Laubender, Rüdiger P.; Göke, Burkhard; Seiderer, Julia; Brand, Stephan; Ochsenkühn, Thomas
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 23:Number 7(2014:Jul.)
Page Start:
735
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. SAFETY OF PERIOPERATIVE BIOLOGICS IN PATIENTS WITH IBD UNDERGOING RESECTIVE BOWEL SURGERY: THE MUNICH IBD CENTER EXPERIENCE. (26th January 2023)

Authors:
Ochsenkühn, Thomas; Waggershauser, Constanze; Tillack-Schreiber, Cornelia; Braun, Isabel; Sohn, Maximilian; Bader, Franz; Munich, June; Schnitzler, Fabian
Journal:
Inflammatory bowel diseases
Issue:
Volume 29(2023)Supplement 1
Page Start:
S2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗